Assyro AI

Orange Book product · Generic (ANDA)

OTICAIR

HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Generic (ANDA)ANDA 064065TE ATRX BAUSCH AND LOMB INC

At a glance

Aug 28, 1996

Approved

Generic (ANDA)

Application

AT

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 28, 1996

    30 yr 3 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Strength

1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML

Dosage form

SUSPENSION/DROPS

Route

OTIC

TE code

AT

Application

ANDA 064065

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.